Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Beam Global (BEEM) Reports Q2 Loss, Lags Revenue Estimates
Beam Global (BEEM) Reports Q2 Loss, Lags Revenue Estimates

Beam Global (BEEM) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.14 per share a year ago. These figures are

Gambling.com Group Limited (GAMB) Q2 Earnings and Revenues Beat Estimates
Gambling.com Group Limited (GAMB) Q2 Earnings and Revenues Beat Estimates

Gambling.com Group Limited (GAMB) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.2 per share a year

ESS Tech, Inc. (GWH) Reports Q2 Loss, Lags Revenue Estimates
ESS Tech, Inc. (GWH) Reports Q2 Loss, Lags Revenue Estimates

ESS Tech, Inc. (GWH) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to a loss of $1.8 per share a year ago. These figures are

Strattec Security (STRT) Beats Q4 Earnings and Revenue Estimates
Strattec Security (STRT) Beats Q4 Earnings and Revenue Estimates

Strattec Security (STRT) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.39 per share a year ago. These

Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates
Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates

Cibus (CBUS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to a loss of $1.14 per share a year ago. These figures are

Dragonfly Energy Holdings Corp. (DFLI) Reports Q2 Loss, Tops Revenue Estimates
Dragonfly Energy Holdings Corp. (DFLI) Reports Q2 Loss, Tops Revenue Estimates

Dragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $1.29. This compares to a loss of $1.98 per share a year

Compared to Estimates, Applied Materials (AMAT) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Applied Materials (AMAT) Q3 Earnings: A Look at Key Metrics

Applied Materials (AMAT) reported $7.3 billion in revenue for the quarter ended July 2025, representing a year-over-year increase of 7.7%. EPS of $2.48 for the same period compares to $2.12 a year

Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates
Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates

Plus Therapeutics (PSTV) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.71 per share a year ago. These

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue EstimatesPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates

IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago. These figures

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago

Genasys (GNSS) Reports Q3 Loss, Beats Revenue Estimates
Genasys (GNSS) Reports Q3 Loss, Beats Revenue Estimates

Genasys (GNSS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.15 per share a year ago. These figures are

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates

RenovoRx, Inc. (RNXT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago. These figures are adjusted

Profound Medical (PROF) Reports Q2 Loss, Misses Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates

Profound Medical (PROF) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.28 per share a year ago. These figures

Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates
Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates

Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.02 per share a year

Guidance Watch: 2 Companies Bullishly Raising Forecasts
Guidance Watch: 2 Companies Bullishly Raising Forecasts

The 2025 Q2 earnings cycle is slowly winding down, which has been resilient so far.

For the 457 S&P 500 companies that have reported Q2 results as of August 13th, total earnings are up +11.6% from

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago. These

Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates

Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.25 per share a year ago. These

Applied Materials (AMAT) Q3 Earnings and Revenues Beat Estimates
Applied Materials (AMAT) Q3 Earnings and Revenues Beat Estimates

Applied Materials (AMAT) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $2.34 per share. This compares to earnings of $2.12 per share a year ago. These

Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to earnings of $1.52 per share a year ago. These

MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates

MacroGenics (MGNX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.89 per share a year ago. These figures are

Do Stocks Have the Fuel To Move Higher?
Do Stocks Have the Fuel To Move Higher?

 

Including this morning’s results from Deere & Company DE, Tapestry TPR and others, we now have Q2 results from 461 S&P 500 members or 92.2% of the index’s total membership. Total earnings for

Do Options Traders Know Something About FBIZ Stock We Don't?
Do Options Traders Know Something About FBIZ Stock We Don't?

Investors in First Business Financial Services, Inc. FBIZ need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $55 Call had some

Is the Options Market Predicting a Spike in Hope Bancorp Stock?
Is the Options Market Predicting a Spike in Hope Bancorp Stock?

Investors in Hope Bancorp, Inc. HOPE need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $7.5 Call had some of the highest

Buy or Avoid the Drop in Chipotle & Cava Group's Stock?
Buy or Avoid the Drop in Chipotle & Cava Group's Stock?

Known for generating massive gains for investors, Chipotle CMG and Cava Group CAVA have seen their stocks fall mightily to 52-week lows following their lackluster Q2 results.

This comes as the Zacks

Top Analyst Reports for Merck, Palo Alto & Freeport
Top Analyst Reports for Merck, Palo Alto & Freeport

Thursday, August 14, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Merck &